Polymorphs of N-malonyl-bis(N′-methyl-N′-thiobenzoylhydrazide)
At least 70% by weight of Compound 1 is the single crystalline form, Form A, Form C, or Form D, of the compound. A pharmaceutical composition comprises a pharmaceutically acceptable carrier or diluent, and compound 1, wherein at least 70% by weight of the compound is the single crystalline form, For...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | DZIEWISZEK JOANNA CHOI JUN Y KOSTIK ELENA SUN LIJUN |
description | At least 70% by weight of Compound 1 is the single crystalline form, Form A, Form C, or Form D, of the compound. A pharmaceutical composition comprises a pharmaceutically acceptable carrier or diluent, and compound 1, wherein at least 70% by weight of the compound is the single crystalline form, Form A, Form C, or Form D, of the compound. A method of treating a subject with cancer comprises administering to the subject an effective amount of compound 1 or the pharmaceutical composition. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US9051250B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US9051250B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US9051250B23</originalsourceid><addsrcrecordid>eNrjZHAKyM-pzM0vKsgoVshPU_DTzU3Myc-rzNFNyizW8HvUsEk3N7UkA8gHs0syMvOTUvOq8itzMipTihKrMlNSNXkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSXxosKWBqaGRqYGTkTERSgDCVTPF</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Polymorphs of N-malonyl-bis(N′-methyl-N′-thiobenzoylhydrazide)</title><source>esp@cenet</source><creator>DZIEWISZEK JOANNA ; CHOI JUN Y ; KOSTIK ELENA ; SUN LIJUN</creator><creatorcontrib>DZIEWISZEK JOANNA ; CHOI JUN Y ; KOSTIK ELENA ; SUN LIJUN</creatorcontrib><description>At least 70% by weight of Compound 1 is the single crystalline form, Form A, Form C, or Form D, of the compound. A pharmaceutical composition comprises a pharmaceutically acceptable carrier or diluent, and compound 1, wherein at least 70% by weight of the compound is the single crystalline form, Form A, Form C, or Form D, of the compound. A method of treating a subject with cancer comprises administering to the subject an effective amount of compound 1 or the pharmaceutical composition.</description><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150609&DB=EPODOC&CC=US&NR=9051250B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150609&DB=EPODOC&CC=US&NR=9051250B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DZIEWISZEK JOANNA</creatorcontrib><creatorcontrib>CHOI JUN Y</creatorcontrib><creatorcontrib>KOSTIK ELENA</creatorcontrib><creatorcontrib>SUN LIJUN</creatorcontrib><title>Polymorphs of N-malonyl-bis(N′-methyl-N′-thiobenzoylhydrazide)</title><description>At least 70% by weight of Compound 1 is the single crystalline form, Form A, Form C, or Form D, of the compound. A pharmaceutical composition comprises a pharmaceutically acceptable carrier or diluent, and compound 1, wherein at least 70% by weight of the compound is the single crystalline form, Form A, Form C, or Form D, of the compound. A method of treating a subject with cancer comprises administering to the subject an effective amount of compound 1 or the pharmaceutical composition.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHAKyM-pzM0vKsgoVshPU_DTzU3Myc-rzNFNyizW8HvUsEk3N7UkA8gHs0syMvOTUvOq8itzMipTihKrMlNSNXkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSXxosKWBqaGRqYGTkTERSgDCVTPF</recordid><startdate>20150609</startdate><enddate>20150609</enddate><creator>DZIEWISZEK JOANNA</creator><creator>CHOI JUN Y</creator><creator>KOSTIK ELENA</creator><creator>SUN LIJUN</creator><scope>EVB</scope></search><sort><creationdate>20150609</creationdate><title>Polymorphs of N-malonyl-bis(N′-methyl-N′-thiobenzoylhydrazide)</title><author>DZIEWISZEK JOANNA ; CHOI JUN Y ; KOSTIK ELENA ; SUN LIJUN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US9051250B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>DZIEWISZEK JOANNA</creatorcontrib><creatorcontrib>CHOI JUN Y</creatorcontrib><creatorcontrib>KOSTIK ELENA</creatorcontrib><creatorcontrib>SUN LIJUN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DZIEWISZEK JOANNA</au><au>CHOI JUN Y</au><au>KOSTIK ELENA</au><au>SUN LIJUN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Polymorphs of N-malonyl-bis(N′-methyl-N′-thiobenzoylhydrazide)</title><date>2015-06-09</date><risdate>2015</risdate><abstract>At least 70% by weight of Compound 1 is the single crystalline form, Form A, Form C, or Form D, of the compound. A pharmaceutical composition comprises a pharmaceutically acceptable carrier or diluent, and compound 1, wherein at least 70% by weight of the compound is the single crystalline form, Form A, Form C, or Form D, of the compound. A method of treating a subject with cancer comprises administering to the subject an effective amount of compound 1 or the pharmaceutical composition.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US9051250B2 |
source | esp@cenet |
subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY METALLURGY ORGANIC CHEMISTRY |
title | Polymorphs of N-malonyl-bis(N′-methyl-N′-thiobenzoylhydrazide) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T13%3A02%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DZIEWISZEK%20JOANNA&rft.date=2015-06-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS9051250B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |